Week 1 HW: Principles and Practices

1. Biological Engineering Application

I propose developing an AI-assisted genomic analysis tool designed to predict the likelihood that a cell or tissue sample may become cancerous. The system would analyse DNA sequencing data to identify combinations of mutations, disrupted tumour suppressor genes, altered regulatory elements, and epigenetic markers associated with early stages of malignant transformation. By training machine-learning models on large cancer genomics datasets, the platform could detect patterns that indicate elevated cancer risk before visible symptoms or large tumours appear.

The goal of this tool would be to enable earlier detection and preventative intervention in oncology. Current cancer diagnostics often identify disease only after significant cellular transformation has occurred. A predictive genomic system could instead flag high-risk cellular states earlier, allowing clinicians to monitor patients more closely or apply targeted preventative treatments.

In the long term, such technology could improve cancer outcomes by shifting medicine from reactive treatment toward proactive risk prediction and prevention.

2. Governance and Policy Goals

Goal 1: Genetic Privacy and Discrimination Prevention

All patients and individuals involved must be guaranteed that their genomic data is kept private in order to prevent potential discrimination in external contexts such as employment or insurance. Genetic information is highly sensitive, and misuse could lead to unfair treatment if individuals are identified as having a higher risk of developing certain diseases.

In addition, individuals’ privacy and autonomy must be respected. Genomic data should not be used, shared, or analysed without the explicit consent and permission of the individual from whom the data was obtained. Clear policies for data ownership, consent, and access must therefore be established to ensure ethical use of the technology.

Goal 2: Democratise the Use of the Technology and Promote Equitable Access

Another important policy goal is to ensure that this technology is accessible globally rather than restricted to wealthy institutions or countries. Because predictive cancer diagnostics could significantly improve health outcomes and longevity, limiting access would risk widening existing healthcare inequalities.

Sub-goals therefore include building systems and distribution frameworks that allow countries across different economic levels to access the technology. This could involve international collaborations, subsidised programs, or integration with public healthcare systems to ensure that individuals from diverse socioeconomic backgrounds are able to benefit from the tool.

3. Governance actions in response

Governance Action 1

Purpose: Protecting the Privacy and Security of Genomic Data

The purpose of this governance action is to ensure that individuals’ genomic data is protected from misuse. As predictive genomic tools become more common, large amounts of highly sensitive biological data will be collected. Without appropriate safeguards, this information could potentially be accessed or exploited by governments, corporations, or other actors, particularly during periods of political instability. Establishing strong governance mechanisms is therefore necessary to maintain trust and prevent the misuse of biodata.

Design

One potential approach would be the creation of an independent international organisation responsible for managing and securing genomic health data. This organisation would operate independently from national governments and establish global standards for data storage, access control, and ethical use. Its role would be to ensure that genomic information collected for medical purposes cannot be repurposed for surveillance, discrimination, or political misuse.

Assumptions

This proposal assumes that the creation of a truly independent global organisation is feasible. In practice, international cooperation in healthcare governance can be difficult to achieve. It is also uncertain whether governments would be willing to allow an external body to manage sensitive health data generated within their jurisdictions.

Risks of Failure and “Success”

This system could fail if the organisation itself becomes corrupt or compromised, as it would ultimately rely on trust and strong oversight. Even if successful, ethical questions may arise regarding who governs the organisation, how decisions are made, and whether all countries would accept its authority.

Governance Action 2

Purpose: Promoting Equitable Access to Predictive Genomic Healthcare

The purpose of this governance action is to ensure that emerging genomic diagnostic technologies do not worsen existing healthcare inequalities. Currently, advanced medical technologies are often disproportionately accessible to wealthier populations, while less affluent communities face financial barriers to care. If predictive genomic tools are introduced without equitable distribution mechanisms, they could primarily benefit those with greater economic resources.

Design

To address this issue, governments could support the subsidisation and large-scale deployment of genomic diagnostic infrastructure. Public funding could be used to minimise the cost of implementing the technology and to distribute diagnostic systems according to population needs. By integrating such tools into public healthcare systems, access could be expanded beyond private healthcare markets.

Assumptions

This proposal assumes that governments would be willing to allocate sufficient funding to support large-scale implementation. It also assumes that the technology itself can be developed and deployed at a cost that makes widespread access feasible.

Risks of Failure and “Success”

This strategy could fail if funding is insufficient or if political priorities shift away from healthcare investment. Additionally, even if the technology becomes widely available, wealthier individuals may still gain preferential access through private healthcare systems, potentially limiting the intended benefits of equitable distribution.

Policy Of Urgence

I consider ensuring the privacy and security of genomic data to be the highest priority among the governance policies considered. Genomic information is highly sensitive and uniquely identifiable, and large-scale genomic databases could potentially be misused if appropriate safeguards are not implemented. In extreme cases, access to detailed genetic information could be exploited not only against individuals, for example through discrimination or surveillance, but potentially at a broader scale in contexts such as targeted biological threats.

For this reason, it is essential that large volumes of genomic data are stored securely and governed by strict access controls. Robust governance frameworks should ensure that such data are used exclusively for legitimate medical research and healthcare purposes. Protecting genomic privacy is therefore critical for maintaining public trust and ensuring that advances in predictive genomic technologies contribute positively to society.